Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | PHGDH | O43175 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL931848 | 0.80 | MEN1 (0.42) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL20333509 | 0.71 | MEN1 (0.35) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL625122 | 0.71 | KMT2A (0.44) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL27500132 | 0.71 | KMT2A (0.44) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL15400452 | 0.70 | NPSR1 (0.39) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL18651747 | 0.67 | MEN1 (0.37) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL23719334 | 0.67 | ALDH1A1 (0.38) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL7845755 | 0.66 | — | — | |
| Ethane SCHEMBL9330415 | 0.66 | NPSR1 (0.43) | MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL216462 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10464960-B2 | Salen complexes with dianionic counterions | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2019-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10464960-B2 | Salen complexes with dianionic counterions | NCLN, POLN, NCL | MEN1 942/4885KMT2A 3824/4885SMN1; SMN2 949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.